The AI Acceleration Paradox: Why Faster Drug Discovery Needs a Smarter Lab
Part 1 of 3: AI & the Future of Protein Drug Discovery in APAC When I started my research career as a bench trainee at the University of Würzburg in the early 2000s, I focused on the specificity of human synovial B-lymphocytes in rheumatoid arthritis and the characterization of protein targets using tools such as…
